Angiotech Triumphs In Stent Patent Appeal
Marking the latest triumph for Angiotech Pharmaceuticals Inc. in its bid to protect its drug-coated coronary stent patent throughout Europe, the company on Thursday said the European Patent Office in Munich,...To view the full article, register now.
Already a subscriber? Click here to view full article